Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michelle R. Glass"'
Autor:
Michelle R. Glass, Michael A. Davies, Alexander J. Lazar, Sapna Pradyuman Patel, Carol Vaughn, Patricia LoRusso, Kevin B. Kim, Roger B. Cohen, Ping Liu, Jeffrey R. Infante, Nicholas E. Papadopoulos
Publikováno v:
Cancer. 119:799-805
BACKGROUND: The high prevalence of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) and neuroblastoma v-ras oncogene homolog (NRAS) mutations in melanoma provides a strong rationale to test the clinical efficacy of mitogen-activated protein kina
Autor:
Nicholas E. Papadopoulos, Wen-Jen Hwu, Jade Homsi, Laurent Vernillet, Agop Y. Bedikian, Patrick Hwu, Patrick J. Rudewicz, Michelle R. Glass, Suzanne Cain, Kevin B. Kim
Publikováno v:
Cancer Investigation. 27:756-763
INO-1001 is a PARP-1 inhibitor that interrupts the repair process of N-methylpurines generated by temozolomide. We evaluated the pharmacokinetics of INO-1001 and determined its safety when used with temozolomide at 200 mg/m(2)/day x 5 days every 4 we
Autor:
Kevin B. Kim, Michelle R. Glass, Sapna Pradyuman Patel, Jessica Ann Chacon, John McMannis, Renjith Ramachandran, Sandy Mahoney, Gladys Alvarado, Elizabeth J. Shpall, Valen E. Johnson, Wen-Jen Hwu, Patrick Hwu, Agop Y. Bedikian, Rahmatu Mansaray, Seth Wardell, Jeffrey E. Gershenwald, Janice N. Cormier, Christopher Toth, Richard Wu, Jeffrey E. Lee, Orenthial J. Fulbright, Patricia S. Fox, Laszlo Radvanyi, Priscilla W. Miller, Michael A. Davies, Richard E. Royal, Minying Zhang, Audrey M. Gonzalez, Gregory Lizée, Chantale Bernatchez, Victor G. Prieto, Anthony Lucci, Jade Homsi, Nicholas Papadopoulos, Merrick I. Ross
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 18(24)
Purpose: Adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) is a promising treatment for metastatic melanoma unresponsive to conventional therapies. We report here on the results of an ongoing phase II clinical trial te
Autor:
Sapna P, Patel, Alexander J, Lazar, Nicholas E, Papadopoulos, Ping, Liu, Jeffrey R, Infante, Michelle R, Glass, Carol S, Vaughn, Patricia M, LoRusso, Roger B, Cohen, Michael A, Davies, Kevin B, Kim
Publikováno v:
Cancer. 119(4)
The high prevalence of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) and neuroblastoma v-ras oncogene homolog (NRAS) mutations in melanoma provides a strong rationale to test the clinical efficacy of mitogen-activated protein kinase kinase (M